Nola Masterson is an experienced global executive and board leader serving on public company, venture-backed private company and non- profit organization boards. Her successful business experience, as CEO and co- founder of Sequenom, (SQNM) and the first analyst in biotechnology on Wall Street with Drexel Burnham Lambert and Merrill Lynch, followed successful business building at Millipore for eight years. She has experience in managing her own venture fund, as well as being a Venture Partner in a major European IT and life sciences venture fund, TVM Capital. During her 10 years on the Repros Therapeutics (RPRX) Board she has advised the CEO on strategy, finance, operations, and recruitment of the board. Areas of expertise include medical device, pharmaceuticals, scientific tools, separation processes and diagnostics technology as well as genetic analysis.